Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion
Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational m...
Uložené v:
| Vydané v: | European journal of surgical oncology Ročník 37; číslo 2; s. 181 - 185 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
01.02.2011
|
| Predmet: | |
| ISSN: | 0748-7983, 1532-2157, 1532-2157 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics.
Patients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3).
Between May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups (
p
<
0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age (
p
=
0.03) and the presence of vascular invasion (
p
=
0.03) were the most powerful predictors of distant metastasis.
Survival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation. |
|---|---|
| AbstractList | Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics.
Patients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3).
Between May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups (
p
<
0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age (
p
=
0.03) and the presence of vascular invasion (
p
=
0.03) were the most powerful predictors of distant metastasis.
Survival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation. Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics. Patients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3). Between May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups (p<0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age (p=0.03) and the presence of vascular invasion (p=0.03) were the most powerful predictors of distant metastasis. Survival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation. Abstract Introduction Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics. Methods Patients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3). Results Between May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups ( p < 0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age ( p = 0.03) and the presence of vascular invasion ( p = 0.03) were the most powerful predictors of distant metastasis. Conclusions Survival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation. Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics.INTRODUCTIONFollicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for FTC following multimodality treatment, with particular reference to the degree of capsular and vascular invasion and to recommend a rational management approach based on these characteristics.Patients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3).METHODSPatients with histologically confirmed FTC were identified from a prospectively maintained database. Details of intervention and long-term outcomes were obtained. Outcomes were compared between patients with minimally invasive follicular carcinoma (MI FTC) without vascular invasion (Group 1); angioinvasive MI FTC (Group 2); and those with widely invasive FTC (Group 3).Between May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups (p<0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age (p=0.03) and the presence of vascular invasion (p=0.03) were the most powerful predictors of distant metastasis.RESULTSBetween May 1983 and December 2008, 124 patients with FTC were identified. The overall disease-free survival rate was 85% at a median of 40 months follow-up. Disease-free survival was 97%, 81% and 46%, respectively, in Groups 1, 2 and 3, and significantly different between groups (p<0.001). Thirteen patients in this series developed distant metastases including 2 in Group 1 and 6 in Group 2. Only patients <45 years of age with MI FTC and no vascular invasion had 100% disease-free survival. After multivariate linear regression, age (p=0.03) and the presence of vascular invasion (p=0.03) were the most powerful predictors of distant metastasis.Survival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation.CONCLUSIONSSurvival is improved in those with minimally invasive compared with widely invasive FTC. In patients <45 years with MI FTC without vascular invasion, hemithyroidectomy may be adequate treatment. All other patients with FTC should undergo total thyroidectomy and radioactive iodine ablation. |
| Author | Learoyd, D.L. Sidhu, S.B. Delbridge, L.W. Vaughan, L. O’Neill, C.J. Sywak, M.S. |
| Author_xml | – sequence: 1 givenname: C.J. surname: O’Neill fullname: O’Neill, C.J. organization: University of Sydney Endocrine Surgical Unit, St Leonards, NSW, Australia – sequence: 2 givenname: L. surname: Vaughan fullname: Vaughan, L. organization: University of Sydney Endocrine Surgical Unit, St Leonards, NSW, Australia – sequence: 3 givenname: D.L. surname: Learoyd fullname: Learoyd, D.L. organization: Department of Endocrinology, Royal North Shore Hospital, St Leonards, NSW, Australia – sequence: 4 givenname: S.B. surname: Sidhu fullname: Sidhu, S.B. organization: University of Sydney Endocrine Surgical Unit, St Leonards, NSW, Australia – sequence: 5 givenname: L.W. surname: Delbridge fullname: Delbridge, L.W. organization: University of Sydney Endocrine Surgical Unit, St Leonards, NSW, Australia – sequence: 6 givenname: M.S. surname: Sywak fullname: Sywak, M.S. email: marksywak@nebsc.com.au organization: University of Sydney Endocrine Surgical Unit, St Leonards, NSW, Australia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21144693$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUk1v1DAUtFAR3S78AQ4oN05ZbMdJHISQqoovqYgDcLZe7JfWwbEXO1lp_z0O214qUS629TQzT56ZC3Lmg0dCXjK6Y5Q1b8YdjinsOF0HbEdp_YRsWF3xkrO6PSMb2gpZtp2szslFSiOltKva7hk554wJ0XTVhixfwcMNTujnIgzFEJyzenEQi_n2GIM1hYaorQ8TFOk2LM4UPRbWG3uwZgFnE-YJrGfwhcGbiLgKadinvzLgTXGAdNK0Pj9t8M_J0wFcwhd395b8_Pjhx9Xn8vrbpy9Xl9elFg2bS2GgHvQgOHSNkKw1UtLKUD5UBuuuNrznrWmrrm86zrHmDRPAedPLBqqWC1NtyeuT7j6G3wumWU02aXQOPIYlKSlkI1vOZEa-ukMu_YRG7aOdIB7VvVMZIE8AHUNKEQel7Qxz_swcwTrFqFpDUaNaQ1FrKIoxlUPJVP6Aeq_-KOndiYTZn4PFqJK26DUaG1HPygT7OP39A7p21lsN7hceMY1hiT47r5hKXFH1fa3K2hSWS1K32eYteftvgf9t_wPCrM7- |
| CitedBy_id | crossref_primary_10_1007_s12672_018_0345_6 crossref_primary_10_1016_j_anl_2017_05_002 crossref_primary_10_1177_01455613231154063 crossref_primary_10_3904_kjim_2014_29_3_325 crossref_primary_10_1016_j_clon_2017_01_006 crossref_primary_10_1016_j_ejso_2017_07_004 crossref_primary_10_1245_s10434_022_13089_5 crossref_primary_10_1016_j_prp_2025_156004 crossref_primary_10_1089_thy_2019_0263 crossref_primary_10_1007_s00104_025_02276_1 crossref_primary_10_1007_s12020_016_0876_y crossref_primary_10_1002_cncy_22375 crossref_primary_10_1002_hed_23511 crossref_primary_10_1016_j_cireng_2015_06_012 crossref_primary_10_1007_s15015_015_1825_y crossref_primary_10_1177_1010428317713913 crossref_primary_10_1016_j_saa_2018_06_010 crossref_primary_10_4158_EP_2018_0052 crossref_primary_10_1016_S1773_035X_21_00376_2 crossref_primary_10_1210_clinem_dgae581 crossref_primary_10_1007_s12022_024_09828_x crossref_primary_10_1016_j_anndiagpath_2018_12_007 crossref_primary_10_1007_s12022_018_9548_1 crossref_primary_10_1111_cen_14693 crossref_primary_10_1007_s00268_016_3608_9 crossref_primary_10_1007_s00423_013_1057_6 crossref_primary_10_1210_clinem_dgad689 crossref_primary_10_1007_s00423_013_1140_z crossref_primary_10_1089_thy_2020_0921 crossref_primary_10_1089_thy_2015_0297 crossref_primary_10_1111_cen_12515 crossref_primary_10_3389_fsurg_2022_995859 crossref_primary_10_1007_s00423_018_1657_2 crossref_primary_10_1007_s12022_017_9483_6 crossref_primary_10_1016_j_path_2022_09_005 crossref_primary_10_1007_s12022_022_09707_3 crossref_primary_10_1038_nrdp_2015_77 crossref_primary_10_1007_s00428_025_04045_1 crossref_primary_10_3390_cancers11091230 crossref_primary_10_1007_s00268_023_07127_w crossref_primary_10_1155_2014_952095 crossref_primary_10_2147_IJGM_S313468 crossref_primary_10_1007_s13193_016_0610_5 crossref_primary_10_1007_s00761_019_0616_z crossref_primary_10_1007_s12022_024_09812_5 crossref_primary_10_1111_pin_12737 crossref_primary_10_1038_s41379_021_00907_6 crossref_primary_10_1016_j_sempedsurg_2020_150920 crossref_primary_10_1007_s12020_021_02717_x crossref_primary_10_1002_cncy_22905 crossref_primary_10_1089_thy_2015_0020 crossref_primary_10_3390_cancers11081100 crossref_primary_10_1007_s12020_015_0649_z crossref_primary_10_1007_s00292_019_00699_2 crossref_primary_10_1210_clinem_dgae122 crossref_primary_10_1038_nrendo_2012_102 crossref_primary_10_1245_s10434_020_09397_3 crossref_primary_10_1245_s10434_022_11401_x crossref_primary_10_1016_j_heliyon_2022_e11783 crossref_primary_10_1053_j_semdp_2020_02_003 crossref_primary_10_1089_thy_2018_0306 crossref_primary_10_1007_s12022_019_9565_8 crossref_primary_10_1186_s12957_015_0612_8 crossref_primary_10_1371_journal_pone_0155489 crossref_primary_10_1007_s00268_022_06696_6 crossref_primary_10_1097_SLA_0000000000003580 crossref_primary_10_1097_MD_0000000000012814 crossref_primary_10_3390_cancers13061270 crossref_primary_10_1002_hed_25721 crossref_primary_10_25122_jml_2023_0270 crossref_primary_10_1097_CCO_0000000000001012 crossref_primary_10_1007_s00268_017_4206_1 crossref_primary_10_1111_his_13335 crossref_primary_10_3389_fonc_2022_816427 crossref_primary_10_1089_thy_2023_0032 crossref_primary_10_3803_EnM_2025_2465 crossref_primary_10_1177_1066896918755008 crossref_primary_10_1016_j_beem_2019_101292 crossref_primary_10_1016_j_endoen_2014_06_019 crossref_primary_10_1016_S0003_4266_16_30008_7 crossref_primary_10_1111_ans_16652 |
| Cites_doi | 10.1097/00000478-198604000-00003 10.1016/S0039-6060(98)70036-4 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 10.1002/1097-0142(20010201)91:3<505::AID-CNCR1029>3.0.CO;2-6 10.1385/EP:16:4:279 10.1385/EP:12:4:417 10.1111/j.1365-2559.2004.01729.x 10.1111/j.1440-1827.2009.02378.x 10.1210/jc.80.10.2946 10.1002/cncr.20081 10.1089/105072504323150778 10.1002/cncr.10683 10.1007/PL00012284 10.1046/j.1445-2197.2002.02556.x 10.1002/(SICI)1097-0347(199603/04)18:2<118::AID-HED2>3.0.CO;2-4 10.1097/01.pap.0000138143.34505.02 10.1016/j.suronc.2007.05.004 10.1038/bjc.1989.47 10.1007/s00268-002-6668-y 10.1038/modpathol.3880023 10.1097/SLA.0b013e3181a77b7b 10.1097/01.sla.0000186421.30982.d2 10.1002/(SICI)1097-0347(199801)20:1<26::AID-HED5>3.0.CO;2-5 10.1677/erc.0.0110131 10.1136/jcp.2006.038604 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Ltd Elsevier Ltd Copyright © 2010 Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright © 2010 Elsevier Ltd. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ejso.2010.11.005 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-2157 |
| EndPage | 185 |
| ExternalDocumentID | 21144693 10_1016_j_ejso_2010_11_005 S0748798310005780 1_s2_0_S0748798310005780 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
| GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABMAC ABMZM ABWVN ABXDB ACDAQ ACIEU ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 X7M Z5R ZGI ZXP ~G- ~HD AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU LCYCR 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c461t-4da5fcf42a964817d8803d02f3de595d2b27d739b6922e52614a226b86a3724d3 |
| ISICitedReferencesCount | 102 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000287616800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0748-7983 1532-2157 |
| IngestDate | Sun Sep 28 10:04:37 EDT 2025 Wed Feb 19 01:47:29 EST 2025 Tue Nov 18 22:28:26 EST 2025 Sat Nov 29 03:24:13 EST 2025 Fri Feb 23 02:26:39 EST 2024 Sun Feb 23 10:18:44 EST 2025 Tue Oct 14 19:31:18 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Adenocarcinoma Thyroid neoplasms Thyroid nodule Follicular |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2010 Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c461t-4da5fcf42a964817d8803d02f3de595d2b27d739b6922e52614a226b86a3724d3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| PMID | 21144693 |
| PQID | 848687218 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_848687218 pubmed_primary_21144693 crossref_citationtrail_10_1016_j_ejso_2010_11_005 crossref_primary_10_1016_j_ejso_2010_11_005 elsevier_sciencedirect_doi_10_1016_j_ejso_2010_11_005 elsevier_clinicalkeyesjournals_1_s2_0_S0748798310005780 elsevier_clinicalkey_doi_10_1016_j_ejso_2010_11_005 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-02-01 |
| PublicationDateYYYYMMDD | 2011-02-01 |
| PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | European journal of surgical oncology |
| PublicationTitleAlternate | Eur J Surg Oncol |
| PublicationYear | 2011 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Gemsenjager, Heitz, Martina (bib29) 1997; 21 Sanders, Silverman (bib19) 1998; 124 Collini, Sampietro, Pilotti (bib15) 2004; 44 Heffess, Thompson (bib8) 2001; 12 Lang, Choritz, Hundeshagen (bib13) 1986; 10 Shaha, Shah, Loree (bib25) 1998; 20 Hedinger, Williams, Sobin (bib9) 1988 Baloch, LiVolsi, Baloch (bib11) 2007; 60 Passler, Scheuba, Prager (bib7) 2004; 11 Chow, Law, Mendenhall (bib21) 2002; 95 D’Avanzo, Treseler, Ituarte (bib14) 2004; 100 Lin, Chao, Chen (bib24) 2007; 16 van Heerden, Hay, Goellner (bib17) 1992; 112 Asari, Koperek, Scheuba (bib20) 2009; 249 D’Avanzo, Ituarte, Treseler (bib23) 2004; 14 DeGroot, Kaplan, Shukla (bib6) 1995; 80 Delbridge, Parkyn, Philips (bib16) 2002; 72 Hundahl, Fleming, Fremgen (bib1) 1998; 83 Lo, Chan, Lam (bib18) 2005; 242 Kakudo, Bai, Katayama (bib3) 2009; 59 Rosai (bib26) 2005; 16 DeLellis, Lloyd, Heitz (bib2) 2004 Thoresen, Akslen, Glattre (bib4) 1989; 59 LiVolsi, Baloch (bib10) 2004; 11 Witte, Goretzki, Dieken (bib28) 2002; 26 Goldstein, Czako, Neill (bib22) 2000; 13 Thompson, Wieneke, Paal (bib12) 2001; 91 Lang, Lo, Chan (bib5) 2007; 14 Rao, Parikh, Deshmane (bib27) 1996; 18 DeLellis (10.1016/j.ejso.2010.11.005_bib2) 2004 van Heerden (10.1016/j.ejso.2010.11.005_bib17) 1992; 112 Kakudo (10.1016/j.ejso.2010.11.005_bib3) 2009; 59 Heffess (10.1016/j.ejso.2010.11.005_bib8) 2001; 12 Lang (10.1016/j.ejso.2010.11.005_bib13) 1986; 10 Delbridge (10.1016/j.ejso.2010.11.005_bib16) 2002; 72 Chow (10.1016/j.ejso.2010.11.005_bib21) 2002; 95 Goldstein (10.1016/j.ejso.2010.11.005_bib22) 2000; 13 Collini (10.1016/j.ejso.2010.11.005_bib15) 2004; 44 Passler (10.1016/j.ejso.2010.11.005_bib7) 2004; 11 LiVolsi (10.1016/j.ejso.2010.11.005_bib10) 2004; 11 D’Avanzo (10.1016/j.ejso.2010.11.005_bib14) 2004; 100 Asari (10.1016/j.ejso.2010.11.005_bib20) 2009; 249 Shaha (10.1016/j.ejso.2010.11.005_bib25) 1998; 20 Rao (10.1016/j.ejso.2010.11.005_bib27) 1996; 18 Hundahl (10.1016/j.ejso.2010.11.005_bib1) 1998; 83 Rosai (10.1016/j.ejso.2010.11.005_bib26) 2005; 16 Hedinger (10.1016/j.ejso.2010.11.005_bib9) 1988 Lin (10.1016/j.ejso.2010.11.005_bib24) 2007; 16 Lang (10.1016/j.ejso.2010.11.005_bib5) 2007; 14 DeGroot (10.1016/j.ejso.2010.11.005_bib6) 1995; 80 Baloch (10.1016/j.ejso.2010.11.005_bib11) 2007; 60 Thompson (10.1016/j.ejso.2010.11.005_bib12) 2001; 91 Lo (10.1016/j.ejso.2010.11.005_bib18) 2005; 242 Gemsenjager (10.1016/j.ejso.2010.11.005_bib29) 1997; 21 Thoresen (10.1016/j.ejso.2010.11.005_bib4) 1989; 59 D’Avanzo (10.1016/j.ejso.2010.11.005_bib23) 2004; 14 Sanders (10.1016/j.ejso.2010.11.005_bib19) 1998; 124 Witte (10.1016/j.ejso.2010.11.005_bib28) 2002; 26 |
| References_xml | – volume: 124 start-page: 967 year: 1998 end-page: 974 ident: bib19 article-title: Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy publication-title: Surgery – volume: 80 start-page: 2946 year: 1995 end-page: 2953 ident: bib6 article-title: Morbidity and mortality in follicular thyroid cancer publication-title: J Clin Endocrinol Metab – volume: 59 start-page: 231 year: 1989 end-page: 235 ident: bib4 article-title: Survival and prognostic factors in differentiated thyroid cancer – a multivariate analysis of 1,055 cases publication-title: Br J Cancer – volume: 14 start-page: 453 year: 2004 end-page: 458 ident: bib23 article-title: Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome publication-title: Thyroid – volume: 11 start-page: 131 year: 2004 end-page: 139 ident: bib7 article-title: Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region publication-title: Endocr Relat Cancer – volume: 11 start-page: 279 year: 2004 end-page: 287 ident: bib10 article-title: Follicular neoplasms of the thyroid: view, biases, and experiences publication-title: Adv Anat Pathol – volume: 72 start-page: 844 year: 2002 ident: bib16 article-title: Minimally invasive follicular thyroid cancer: completion thyroidectomy or not? publication-title: Austr N Z J Surg – volume: 60 start-page: 244 year: 2007 end-page: 250 ident: bib11 article-title: Our approach to follicular-patterned lesions of the thyroid publication-title: J Clin Pathol – volume: 13 start-page: 123 year: 2000 end-page: 130 ident: bib22 article-title: Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients publication-title: Mod Pathol – volume: 21 start-page: 546 year: 1997 end-page: 551 ident: bib29 article-title: Selective treatment of differentiated thyroid carcinoma publication-title: World J Surg – volume: 83 start-page: 2638 year: 1998 end-page: 2648 ident: bib1 article-title: A National cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 publication-title: Cancer – volume: 12 start-page: 417 year: 2001 end-page: 422 ident: bib8 article-title: Minimally invasive follicular thyroid carcinoma publication-title: Endocr Pathol – volume: 16 start-page: 279 year: 2005 end-page: 283 ident: bib26 article-title: Handling of thyroid follicular patterned lesions publication-title: Endocr Pathol – volume: 59 start-page: 359 year: 2009 end-page: 367 ident: bib3 article-title: Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute publication-title: Pathol Int – volume: 20 start-page: 26 year: 1998 end-page: 30 ident: bib25 article-title: Patterns of failure in differentiated carcinoma of the thyroid based on risk groups publication-title: Head Neck – volume: 26 start-page: 1017 year: 2002 end-page: 1022 ident: bib28 article-title: Importance of lymph node metastases in follicular thyroid cancer publication-title: World J Surg – volume: 95 start-page: 488 year: 2002 end-page: 498 ident: bib21 article-title: Follicular thyroid carcinoma: prognostic factors and the role of radioiodine publication-title: Cancer – volume: 10 start-page: 246 year: 1986 end-page: 255 ident: bib13 article-title: Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings publication-title: Am J Surg Pathol – volume: 16 start-page: 107 year: 2007 end-page: 113 ident: bib24 article-title: Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging publication-title: Surg Oncol – volume: 100 start-page: 1123 year: 2004 end-page: 1129 ident: bib14 article-title: Follicular thyroid carcinoma: histology and prognosis publication-title: Cancer – volume: 14 start-page: 730 year: 2007 end-page: 738 ident: bib5 article-title: Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging publication-title: Ann Surg Oncol – volume: 44 start-page: 35 year: 2004 end-page: 39 ident: bib15 article-title: Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up publication-title: Histopathology – volume: 249 start-page: 1023 year: 2009 end-page: 1031 ident: bib20 article-title: Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial publication-title: Ann Surg – volume: 242 start-page: 708 year: 2005 end-page: 715 ident: bib18 article-title: Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival publication-title: Ann Surg – year: 2004 ident: bib2 article-title: Pathology and genetics of tumours of endocrine organs – year: 1988 ident: bib9 article-title: Histological typing of thyroid tumours publication-title: International histological classification of tumors – volume: 91 start-page: 505 year: 2001 end-page: 524 ident: bib12 article-title: A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature publication-title: Cancer – volume: 112 start-page: 1130 year: 1992 end-page: 1136 ident: bib17 article-title: Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy publication-title: Surgery – volume: 18 start-page: 118 year: 1996 end-page: 124 ident: bib27 article-title: Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases publication-title: Head Neck – volume: 10 start-page: 246 year: 1986 ident: 10.1016/j.ejso.2010.11.005_bib13 article-title: Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings publication-title: Am J Surg Pathol doi: 10.1097/00000478-198604000-00003 – volume: 124 start-page: 967 year: 1998 ident: 10.1016/j.ejso.2010.11.005_bib19 article-title: Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy publication-title: Surgery doi: 10.1016/S0039-6060(98)70036-4 – volume: 83 start-page: 2638 year: 1998 ident: 10.1016/j.ejso.2010.11.005_bib1 article-title: A National cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 – volume: 91 start-page: 505 year: 2001 ident: 10.1016/j.ejso.2010.11.005_bib12 article-title: A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature publication-title: Cancer doi: 10.1002/1097-0142(20010201)91:3<505::AID-CNCR1029>3.0.CO;2-6 – volume: 16 start-page: 279 year: 2005 ident: 10.1016/j.ejso.2010.11.005_bib26 article-title: Handling of thyroid follicular patterned lesions publication-title: Endocr Pathol doi: 10.1385/EP:16:4:279 – volume: 12 start-page: 417 year: 2001 ident: 10.1016/j.ejso.2010.11.005_bib8 article-title: Minimally invasive follicular thyroid carcinoma publication-title: Endocr Pathol doi: 10.1385/EP:12:4:417 – volume: 112 start-page: 1130 year: 1992 ident: 10.1016/j.ejso.2010.11.005_bib17 article-title: Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy publication-title: Surgery – volume: 44 start-page: 35 year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib15 article-title: Extensive vascular invasion is a marker of risk of relapse in encapsulated non-Hurthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11-year median follow-up publication-title: Histopathology doi: 10.1111/j.1365-2559.2004.01729.x – volume: 59 start-page: 359 year: 2009 ident: 10.1016/j.ejso.2010.11.005_bib3 article-title: Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute publication-title: Pathol Int doi: 10.1111/j.1440-1827.2009.02378.x – volume: 80 start-page: 2946 year: 1995 ident: 10.1016/j.ejso.2010.11.005_bib6 article-title: Morbidity and mortality in follicular thyroid cancer publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.80.10.2946 – volume: 100 start-page: 1123 year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib14 article-title: Follicular thyroid carcinoma: histology and prognosis publication-title: Cancer doi: 10.1002/cncr.20081 – volume: 14 start-page: 453 year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib23 article-title: Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome publication-title: Thyroid doi: 10.1089/105072504323150778 – volume: 95 start-page: 488 year: 2002 ident: 10.1016/j.ejso.2010.11.005_bib21 article-title: Follicular thyroid carcinoma: prognostic factors and the role of radioiodine publication-title: Cancer doi: 10.1002/cncr.10683 – volume: 21 start-page: 546 year: 1997 ident: 10.1016/j.ejso.2010.11.005_bib29 article-title: Selective treatment of differentiated thyroid carcinoma publication-title: World J Surg doi: 10.1007/PL00012284 – volume: 14 start-page: 730 year: 2007 ident: 10.1016/j.ejso.2010.11.005_bib5 article-title: Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging publication-title: Ann Surg Oncol – volume: 72 start-page: 844 year: 2002 ident: 10.1016/j.ejso.2010.11.005_bib16 article-title: Minimally invasive follicular thyroid cancer: completion thyroidectomy or not? publication-title: Austr N Z J Surg doi: 10.1046/j.1445-2197.2002.02556.x – volume: 18 start-page: 118 year: 1996 ident: 10.1016/j.ejso.2010.11.005_bib27 article-title: Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases publication-title: Head Neck doi: 10.1002/(SICI)1097-0347(199603/04)18:2<118::AID-HED2>3.0.CO;2-4 – volume: 11 start-page: 279 year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib10 article-title: Follicular neoplasms of the thyroid: view, biases, and experiences publication-title: Adv Anat Pathol doi: 10.1097/01.pap.0000138143.34505.02 – volume: 16 start-page: 107 year: 2007 ident: 10.1016/j.ejso.2010.11.005_bib24 article-title: Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging publication-title: Surg Oncol doi: 10.1016/j.suronc.2007.05.004 – volume: 59 start-page: 231 year: 1989 ident: 10.1016/j.ejso.2010.11.005_bib4 article-title: Survival and prognostic factors in differentiated thyroid cancer – a multivariate analysis of 1,055 cases publication-title: Br J Cancer doi: 10.1038/bjc.1989.47 – volume: 26 start-page: 1017 year: 2002 ident: 10.1016/j.ejso.2010.11.005_bib28 article-title: Importance of lymph node metastases in follicular thyroid cancer publication-title: World J Surg doi: 10.1007/s00268-002-6668-y – volume: 13 start-page: 123 year: 2000 ident: 10.1016/j.ejso.2010.11.005_bib22 article-title: Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients publication-title: Mod Pathol doi: 10.1038/modpathol.3880023 – volume: 249 start-page: 1023 year: 2009 ident: 10.1016/j.ejso.2010.11.005_bib20 article-title: Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial publication-title: Ann Surg doi: 10.1097/SLA.0b013e3181a77b7b – volume: 242 start-page: 708 year: 2005 ident: 10.1016/j.ejso.2010.11.005_bib18 article-title: Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival publication-title: Ann Surg doi: 10.1097/01.sla.0000186421.30982.d2 – year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib2 – volume: 20 start-page: 26 year: 1998 ident: 10.1016/j.ejso.2010.11.005_bib25 article-title: Patterns of failure in differentiated carcinoma of the thyroid based on risk groups publication-title: Head Neck doi: 10.1002/(SICI)1097-0347(199801)20:1<26::AID-HED5>3.0.CO;2-5 – volume: 11 start-page: 131 year: 2004 ident: 10.1016/j.ejso.2010.11.005_bib7 article-title: Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region publication-title: Endocr Relat Cancer doi: 10.1677/erc.0.0110131 – year: 1988 ident: 10.1016/j.ejso.2010.11.005_bib9 article-title: Histological typing of thyroid tumours – volume: 60 start-page: 244 year: 2007 ident: 10.1016/j.ejso.2010.11.005_bib11 article-title: Our approach to follicular-patterned lesions of the thyroid publication-title: J Clin Pathol doi: 10.1136/jcp.2006.038604 |
| SSID | ssj0009379 |
| Score | 2.3003688 |
| Snippet | Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to describe outcomes for... Abstract Introduction Follicular thyroid carcinoma (FTC) includes a spectrum of neoplasms with varying propensity for metastasis. The aim of this study is to... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 181 |
| SubjectTerms | Adenocarcinoma Adenocarcinoma, Follicular Combined Modality Therapy Disease-Free Survival Female Follicular Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Neoplasm Invasiveness Surgery Thyroid neoplasms Thyroid Neoplasms - pathology Thyroid Neoplasms - therapy Thyroid nodule Vascular Neoplasms - pathology |
| Title | Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0748798310005780 https://www.clinicalkey.es/playcontent/1-s2.0-S0748798310005780 https://dx.doi.org/10.1016/j.ejso.2010.11.005 https://www.ncbi.nlm.nih.gov/pubmed/21144693 https://www.proquest.com/docview/848687218 |
| Volume | 37 |
| WOSCitedRecordID | wos000287616800013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-2157 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009379 issn: 0748-7983 databaseCode: AIEXJ dateStart: 19950201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbKhhAviDvlMvmBtypVLk7sPI5pCCYxkDZQ36wkjmmrkUxNM41_xs_jnNhOtrEO9sCLFbm12-R8OTefCyFvk4QDLvLME0L5Hotj7uUs1p4GRhhogIguRNdsgh8eitks_TIa_XK5MGcnvKrE-Xl6-l9JDXNAbEydvQW5-01hAq6B6DAC2WH8J8IPAS2oCGosum1iTYEkq3qhsBh1sajqH9mkmWOD60mOhUNcXtaiQZ00w7HGQFmwxzu3QpGBPY3boKd9iF-t4NKR9joHv1V2m3ZlWGxdFZcc-Z9dtEWK7ujOH703PZi6j79l7fe5TY_oJ7EmbP3TxCtPh-mjhZq3nTd3-m560ZuB7tk-MsQwPc6Ex1PT3MZxaFMWxiIxvMBuA9PuxUruwDT_-UMoGP_Ecloum9oE82HdVj8eRKA79r8iGft4RRcKt5S4h8Q9wHSSXfHc7ZDHKfDT7d2P-7ODoeCzrfPo7scmbJnYwqv_ZJNStMno6ZSf44fkgbVa6K5B2yMyKqvH5N4nG5fxhLQD6Git6QA6akFHe9BRAzqal_Qy6GgHOlpX1IAON3KgowA66kBHHeiekq_v94_3Pni2oYdXsCRYe0xlsS40C7M0YSLgCoRHpPxQR6qM01iFecgVj9I8ScOwjMG4ZxmYB7lIsoiHTEXPyFZVV-ULQlVQRFFZahZljPE0yLWf6BxLIQml_SIck8A9UVnYavfYdOVEbqblmEz6Naem1suN344coaTLYga5KwF1N67i160qG_tKNjKQTSh9eYTIQeDgARzwTH9M4n6l1Y6N1vvXX6QORRJEB54HZlVZt40UTCSCg44_Js8NuvrbDgP0E6XRy1s9klfk_vBOvyZb61VbviF3i7P1olntkDt8Jnbse_IbyFPwWA |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Management+of+follicular+thyroid+carcinoma+should+be+individualised+based+on+degree+of+capsular+and+vascular+invasion&rft.jtitle=European+journal+of+surgical+oncology&rft.au=O%E2%80%99Neill%2C+C.J.&rft.au=Vaughan%2C+L.&rft.au=Learoyd%2C+D.L.&rft.au=Sidhu%2C+S.B.&rft.date=2011-02-01&rft.issn=0748-7983&rft.volume=37&rft.issue=2&rft.spage=181&rft.epage=185&rft_id=info:doi/10.1016%2Fj.ejso.2010.11.005&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejso_2010_11_005 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07487983%2FS0748798310X00142%2Fcov150h.gif |